Reference

1. Samer El Hayek, Lynn H. Hamdar, Fadi G. Mirza and Georges Daoud.Polycystic Ovarian Syndome: An Updated Overview.Front.Physiol.7: 124. https://doi.org/10.3389/fphys.2016.0012. 
2. Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., and Yildiz, B. O. (2004). The prevalence and features of the polycystic ovary syndrome in an unselected population. J. Clin. Endocrinol. Metab. 89, 2745–2749. https://doi.org/10.1210/jc.2003-032046. 
3. March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ: The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010, 25:544-551. https://doi.org/10.1093/humrep/dep399. 
4. H Teede, A Deeks and L Moran. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Medicine2010,8:41. http://www.biomedcentral.com/1741-7015/8/41.
5. Roe AH, Prochaska E, Smith M, Sammel M, Dokras A. Using the Androgen Excess-PCOS Society criteria to diagnose polycystic ovary syndrome and the risk of metabolic syndrome in adolescents. J Pediatr 2013;162:937–941. https://doi.org/10.1016/j.jpeds.2012.11.019. 
6. Badawy A, Elnashar A. Treatment options for polycystic ovary syndrome. Int J Women’s Health 2011;3:25–35. https://doi.org/10.2147/IJWH.S11304.
7. Fauser BCJM, Tarlatzis BC, Rebar RW, et al. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril 2012;97:28–38. https://doi.org/10.1016/j.fertnstert.2011.09.024. 
8. Balen AH, Conway GS, Kaltsas G, Techatrasak K, Manning PJ, West C, Jacobs HS: Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod 1995, 10:2107-2111. https://doi.org/10.1093/oxfordjournals.humrep.a136243. 
9. Moran LJ, Pasquali R, Teede HJ, Hoeger KM, Norman RJ: Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society. Fertil Steril 2009, 92:1966-1982. https://doi.org/10.1016/j.fertnstert.2008.09.018. 
10. R. J. Norman, M. J. Davies, J. Lord, and L. J. Moran, “The role of lifestyle modification in polycystic ovary syndrome,” Trends in Endocrinology and Metabolism, vol. 13, 2002. https://doi.org/10.1016/s1043-2760(02)00612-4. 
11. Carrie C. Dennett and Judy Simon. The Role of Polycyctic Ovary Syndrome in Reproductive and Metabolic Health: Overview an Approaches for Treatment. https://doi.org/10.2337/diaspect.28.2.116. 
12. C. M. J. Matyanga and B. Dzingirai, “Clinical pharmacology of hormonal emergency contraceptive pills,” International Journal of Reproductive Medicine, vol. 2018. https://doi.org/10.1155/2018/2785839. 
13. Verit FF, Erel O. Oxidative stress in nonobese women with polycystic ovary syndrome: correlations with endocrine and screening parameters. Gynecol Obstet Investig. 2008;65(4):233–9. https://doi.org/10.1159/000113046.
14. Sies H. Oxidative stress: from basic research to clinical application. Am J Med. 1991;91(3):S31–8. https://doi.org/10.1016/0002-9343(91)90281-2.
15. Goodarzi.M.O.etal. Polycycstic ovary syndrome: etiology, pathogenesis and diagnosis.NatRev Endocrinol 2011;7:219–2311. https://doi.org/nrendo2010.217.Epub2011. 
16. Rashmi Saxena Pal, Amrita Mishra.A review on Dhatryadi ghrita.ijrap. https://doi.org/10.7897/2277-4343.082111.
17. OECD Acute Oral toxicity 423.,2001,[01]. https;//ntp.nieghs.nih.gov/iccvam/suppdocs/feddocs/oecd/oecd_gl423.pdf. 
18. Amal H. Hamza, Widad M. AlBishri, Mona H. Alfaris.Effect of Vitex-castus plant extract on polycystic ovary syndrome complications in experimental rat model. apjr.2019;8(2): 63-69. http://doi.org/10.4103/2305-0500.254647. 
19. Anam Younas, Liaqat Hussain, Arham Shabbir, Muhammad Asif, Musaddique Hussain, and Faiza Manzoor.Effects of Fagonia indica on letrozole-induced polycystic ovarian syndrome (PCOS) in young adult female rats. Hindawi.2022.1397060.13. https://doi.org/10.1155/2022/1397060.
20. Yasmine F. Ibrahim, Mohammed Alorabi, Walaa Yehia Abdelzaher, Nisreen DM Toni, Khaled Thabet, AbdelRahman Hegazy, Haitham Ahmed Bahaa, Gaber El-Saber Batiha, Nermeen N. Welson, Mohamed A. Myrosy, Katharigatta N. Venugopala, Asmaa Mohamed Abdel-Aziz.Diacerein ameliorates letrozole-induced polycystic ovarian syndromeinrats.Biomedicine&Pharmacotherapy.149(2022)112870.  https://doi.org/10.1016/j.biopha.2022.112870.